As collaborative research results with Kyoto University,Professor Masafumi Kanai (Graduate School of Medicine, Kyoto University ) announced the anticancer effect of the prodrug curcumin (CMG) at the 15th Annual Meeting of Japanese Society of Clinical Oncology Symposium (2017-7-27), . This content was also posted in the Yomiuri Newspaper the previous day and there was a big reaction.
Opmerkingen